Compounding for growth
Fagron, the leading global player in pharmaceutical compounding, has acquired from Fresenius Kabi a 503B outsourcing facility in Boston.
Together with prescribers and pharmacists, Fagron strives to improve personalized medicine and to make it (more) accessible for patients. In this way, we aim to have a significant impact on the health and welfare of people.
A continuous focus on innovation, quality and efficiency is essential in consolidating our leading market positions. We start by exploring if our values are aligned for a potential partnership.
Fagron is active in 35 countries in EMEA, North America, and Latin America.
We are always keen to get learn more about you. Please fill in the contact form, send an email or call us.
Partnerships with companies that create value in healthcare by offering products and services for compounding personalized medicine.
Fagron is active in the growing market of personalized medicine, always looking for new strategic opportunities